A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
ABOUT US
The I-SCREEN project is developing an AI system using Optical Coherence Tomography (OCT) to detect and profile age-related macular degeneration (AMD), a common cause of vision loss.
Our goal is the early identification as well as the assessment of the risk of progression of AMD through smart AI analysis of detailed retina images. Join us in improving eye health outcomes for everyone.
01.01.24
START DATE
48 MONTH
OF DURATION
4.7 MIL €
BUDGET
WHY IS THIS RESEARCH IMPORTANT
Addressing a pressing healthcare challenge, the I-SCREEN project is committed to combating widespread vision loss caused by age-related macular degeneration (AMD). The mission involves developing an accessible and cost-effective AI-based system for early AMD detection and timely treatment. Utilising artificial intelligence, automated tools are being created for AMD detection and progression monitoring, accessible through cloud technology for real-world screening.
This initiative introduces a unique AI-powered platform designed for OCT scanners in local eye care professional’s offices, aiming to revolutionise AMD patient care with a new concept of AI-driven shared care. With AMD affecting an estimated 67 million citizens in the EU28 (including the UK), this innovative approach leverages AI in precision image analysis to provide a therapeutic chance of benefit and accessible professional eye care for all citizens over 50 through their local optician or optometrist—an unprecedented solution to a pressing healthcare dilemma.